Write the nation's first prescription! The "life-saving drug" Chlorbachan landed

With the efforts of the National Health Commission, the State Food and Drug Administration and other parties, on September 22, Chlorbazhan, once known as a "life-saving drug" as a temporary import of drugs in urgent clinical need, issued the country's first prescription
at Peking Union Medical College Hospital.
Clobazhan is a drug used in the treatment of children with rare refractory epilepsy, which has a very important position in adjuvant therapy, and can be said to be a "life-saving drug"
for the symptomatic and less side effects of such diseases.
However, due to the fact that Chlorobazhan belongs to the second class of psychotropic drugs in China, it has a certain addictiveness, and it has not been approved for listing
in China before.
Ms.
Mao's son was the first child to legally use the Shangyuan research drug chlorbazam in China
.
The child suffered from infantile spasms when she was two years old, and in the group of patients, she knew the news that Chlor Bazhan would be listed in China, and on September 22, she took the child from Hebei to the neurology department of
Peking Union Medical College Hospital.
The child has been taking Clobazhan for nearly 5 years, and has been relying on friends to buy from abroad, often facing the risk of
cutting off the drug.
Such diseases are easy to repeat if they cannot take drugs regularly for a long time, and even bring complications
.
Ms.
Mao: I have been shopping online, and I have been looking for someone from Germany to buy it, but I have always been afraid of buying fake drugs, and I am also very worried
.
Now it is too convenient, because there is no need to worry about buying fake drugs, after all, the hospital must be a regular way to open it, and there is no need to worry about cutting off the
drug.
[We] are very happy, as long as (children) take this medicine parents are certainly very happy
.
In order to meet the needs of patients for a small number of specific clinically urgent drugs that have been listed abroad and are not available in China, in June this year, the National Health Commission and the State Food and Drug Administration jointly formulated and issued the "Temporary Import Work Plan for Clinically Urgently Needed Drugs" and the "Chlorbachan Temporary Import Work Plan"
.
The "Plan" makes it clear that in the 50 tertiary hospitals across the country led by Peking Union Medical College Hospital, imported chlorbachan will be successively landed, and children and their families can purchase chlorbachan
through prescriptions from qualified doctors.
Zhang Bo, Director of the Department of Pharmacy, Peking Union Medical College Hospital: It actually establishes an innovative mechanism for the accessibility of drugs with new Chinese characteristics, which I think also provides a solution for
the accessibility of other rare disease drugs.
We also know that refractory epilepsy actually affects patients, whether it is for children or families, such as his intellectual development, this damage to his body, and mental pressure, I think it is very large
.
Then, with the import of the original research drug Chlorbachchan, I think that patients with this kind of refractory epilepsy in China should receive a very great benefit and solve the problem
of accessibility of the drug.
Medicines for Baby Hospital Disease Counterfeit Medicines